Overview

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Status:
RECRUITING
Trial end date:
2026-05-25
Target enrollment:
Participant gender:
Summary
The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.
Phase:
PHASE3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Chloroquine
Primaquine
tafenoquine